Jin-Suk Cho

Title: Innovations of Jin-Suk Cho in Taxane Derivatives

Introduction

Jin-Suk Cho is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of taxane derivatives. With a total of five patents to his name, Cho's work has the potential to impact cancer treatment significantly.

Latest Patents

One of his latest patents is a method for preparing taxane derivatives. This method involves the condensation of phenylisoserine derivatives with a baccatin III derivative to obtain a mixture of isomers. The process includes separating the isomers via chromatography and reverting the stereochemical structure of a selectively separated isomer. This innovative approach is suitable for producing taxane derivatives on a large scale with high yield.

Another significant patent is for a method of preparing highly pure anhydrous crystalline docetaxel. This method enables the production of docetaxel with a purity of 99.5% or more. The resulting product is particularly useful as an anticancer agent due to its remarkably low residual solvent content, which meets the stringent standards for drug safety.

Career Highlights

Jin-Suk Cho has worked with reputable companies such as Samyang Genex Corporation and Samyang Genexbio Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Moon-Suk Kim and Ho-Joon Choi. Their collaborative efforts have likely played a role in advancing the research and development of innovative pharmaceutical solutions.

Conclusion

Jin-Suk Cho's contributions to the field of taxane derivatives and his innovative methods for preparing highly pure docetaxel highlight his importance as an inventor. His work not only advances scientific knowledge but also has the potential to improve cancer treatment options for patients worldwide.